Health Condition 1: N390- Urinary tract infection, site notspecified
Conditions
Interventions
Intervention1: Lactobacillus acidophilus (2 billion), Lactobacillus bulgaricus (1 billion), Bifidobactaterium bifidum (1 billion), and Fructooligosaccharides (100 mg): Each capsule contains:
Lactobaci
Sponsors
Bangladesh Medical Research Council
Purnava Ltd
Eligibility
Inclusion criteria
Inclusion criteria: i. Sex: female ii.Female suffering from only recurrent uncomplicated UTI iii. Patients have not received any antimicrobial and/or probiotic therapy within one month prior to enrollment in the study. iv. Non-pregnant women
Exclusion criteria
Exclusion criteria: i. Sex: Male ii. Status: Pregnant women ii. Patients received any antimicrobial and/or probiotic therapy within one month prior to enrollment in the study. iii. Patients having relevant interactions of prescribed antimicrobial agent or probiotics with concurrent medication or contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The number of patients is cured of UTI due to administration of probiotics/antibiotics. It will be based on absence or decreased severity of clinical signs-symptoms after completion of course of probiotics and antibiotics. 2.Identification of the organisms responsible for UTI and evaluation of the development of antibiotic resistance by expressing in percentage of antibiotic resistant E. Coli isolate from urine of symptomatic women.Timepoint: At Baseline, 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The micro biologically confirmed recovery of patients suffering from UTI. 2. Proportion of patientsâ?? experienced adverse events.Timepoint: At baseline, 2 weeks and 4 weeks | — |
Countries
Bangladesh
Contacts
Public ContactAbu Syed Md Mosaddek
Uttara Adhunik Medical College
Outcome results
None listed